These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20432403)

  • 1. "Over-and-under" pericardial covered stent with paclitaxel balloon in a saphenous vein graft.
    Wykrzykowska JJ; Gutiérrez-Chico JL; van Geuns RJ
    Catheter Cardiovasc Interv; 2010 May; 75(6):964-6. PubMed ID: 20432403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
    Blackman DJ; Choudhury RP; Banning AP; Channon KM
    J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions.
    Vermeersch P; Agostoni P
    Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
    Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
    Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?
    Vermeersch P; Agostoni P
    J Interv Cardiol; 2005 Dec; 18(6):467-73. PubMed ID: 16336427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolic protection devices in saphenous percutaneous intervention.
    Morís C; Lozano I; Martín M; Rondán J; Avanzas P
    EuroIntervention; 2009 May; 5 Suppl D():D45-50. PubMed ID: 19736070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery.
    Niccoli G; Biscione C; Conte M; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snare extraction of a fractured coronary stent in a saphenous vein graft.
    Steinberg DH; Satler LF; Pichard AD
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):241-3. PubMed ID: 17377995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 11. Vessel diameter should be taken into account in saphenous stenting.
    Lozano I; Rondan J; Avanzas P
    EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787
    [No Abstract]   [Full Text] [Related]  

  • 12. Saphenous vein graft disease.
    Peykar S; Angiolillo DJ; Bass TA; Costa MA
    Minerva Cardioangiol; 2004 Oct; 52(5):379-90. PubMed ID: 15514573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
    Ponnuthurai FA; van Gaal WJ; Channon KM
    J Invasive Cardiol; 2007 Dec; 19(12):E369-71. PubMed ID: 18180530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.
    Jim MH; Ho HH; Ko RL; Siu CW; Yiu KH; Lau CP; Chow WH
    J Interv Cardiol; 2010 Feb; 23(1):40-5. PubMed ID: 20465719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of post-stenotic saphenous vein graft aneurysm: special considerations with the polytetrafluoroethylene-covered stent.
    Ho PC; Leung CY
    J Invasive Cardiol; 2004 Oct; 16(10):604-5. PubMed ID: 15505363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MGuard stent: current promises and limitations.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):642-3. PubMed ID: 20333654
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
    Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.